$229 Million is the total value of Kopp Family Office, LLC's 14 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Buy | Horizon Therapeutics Public Limited Company | $59,130,000 | -0.2% | 548,715 | +1.4% | 25.86% | +9.9% |
| NEO | Sell | NeoGenomics Inc. | $55,014,000 | -36.1% | 1,612,363 | -9.7% | 24.06% | -29.6% |
| IEFA | Buy | ISHARES TRcore msci eafe | $27,141,000 | +7.9% | 363,622 | +7.4% | 11.87% | +18.9% |
| JAMF | Buy | JAMF HOLDING CORP | $22,727,000 | +6.7% | 597,910 | +8.1% | 9.94% | +17.6% |
| VCEL | Sell | Vericel Corporation | $21,351,000 | -20.4% | 543,275 | -1.2% | 9.34% | -12.3% |
| FIVN | Buy | Five9, Inc. | $20,880,000 | +42.8% | 152,055 | +66.1% | 9.13% | +57.3% |
| IEMG | Buy | ISHARES TRcore msci emkt | $17,884,000 | +8.3% | 298,770 | +11.8% | 7.82% | +19.4% |
| MITK | Buy | MITEK SYS INC | $4,200,000 | +136.8% | 236,628 | +146.7% | 1.84% | +160.9% |
| ISTB | Buy | ISHARES TRcore 1 5 yr usd | $112,000 | +6.7% | 2,228 | +8.7% | 0.05% | +16.7% |
| IVV | Sell | ISHARES TRcore s&p500 etf | $112,000 | -11.1% | 234 | -19.9% | 0.05% | -2.0% |
| IAGG | Buy | ISHARES TRcore intl aggr | $47,000 | +9.3% | 862 | +10.1% | 0.02% | +23.5% |
| IMTB | Buy | ISHARES TRcr 5 10 yr etf | $42,000 | +7.7% | 834 | +9.2% | 0.02% | +20.0% |
| IJH | Sell | ISHARES TRcore s&p mcp etf | $35,000 | -10.3% | 122 | -17.0% | 0.02% | 0.0% |
| IJR | Sell | ISHARES TRcore s&p scp etf | $19,000 | -17.4% | 169 | -18.4% | 0.01% | -11.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NeoGenomics Inc. | 16 | Q3 2023 | 90.1% |
| Vericel Corporation | 16 | Q3 2023 | 14.5% |
| Five9, Inc. | 16 | Q3 2023 | 11.2% |
| ISHARES TR | 13 | Q3 2023 | 16.7% |
| ISHARES TR | 13 | Q3 2023 | 10.6% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
View Kopp Family Office, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| RTI Surgical Holdings, Inc. | July 07, 2020 | ? | ? |
| NEOGENOMICS INC | January 07, 2020 | 4,844,625 | 4.6% |
| OCLARO, INC. | January 04, 2019 | ? | ? |
| SUPERCONDUCTOR TECHNOLOGIES INC | October 05, 2018 | ? | ? |
View Kopp Family Office, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-16 |
View Kopp Family Office, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.